SCHEMBL5803128

SCHEMBL5803128

CN1CCN(c2cc(S(=O)(=O)Oc3cccnc3)cc3ccoc23)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.41
CYP3A4 P08684 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
HTR2C P28335 1/20 0.38
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CCNA1 P78396 1/20 0.37
HTR2A P28223 2/20 0.37
HTR6 P50406 2/20 0.37
JAK2 O60674 1/20 0.36
JAK3 P52333 1/20 0.36
PIM1 P11309 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
CYP11B1 P15538 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5824147 0.92 CDK2 (0.38) HRH4CYP3A4ALDH1A1CYP1A2CYP2D6
SCHEMBL5802772 0.89 HTR6 (0.39) HTR2CHTR2AHTR6PIM1
Hydrochloric Acid SCHEMBL5803718 0.88 HTR6 (0.38) HTR2CHTR2AHTR6PIM1
SCHEMBL5804656 0.82 KDM4E (0.41) TSHRHTR6
SCHEMBL5807173 0.79 CA9 (0.38) ALDH1A1HTR6LMNA
SCHEMBL5804780 0.76 DRD2 (0.41) HTR6
Trifluoroacetic Acid SCHEMBL5814494 0.75 KDM4E (0.37) HRH4ALDH1A1TSHRHTR6
Trifluoroacetic Acid SCHEMBL5818377 0.70 HTR1A (0.38) ALDH1A1TSHRHTR6
SCHEMBL3622742 0.68 HTR6 (0.59) CYP3A4ALDH1A1CYP1A2CYP2D6HTR2C
Hydrochloric Acid SCHEMBL1377875 0.68 HTR6 (0.58) CYP3A4ALDH1A1CYP1A2CYP2D6HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060142269-A1 New compounds BIOVITRUM AB (SE) 2006-06-29 US claimed
WO-2006062481-A1 NEW BENZOFURAN DERIVATIVES AND THEIR USE IN THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS . BIOVITRUM AB (SE) 2006-06-15 WO claimed
US-20060142269-A1 New compounds BIOVITRUM AB (SE) 2006-06-29 US disclosed
WO-2006062481-A1 NEW BENZOFURAN DERIVATIVES AND THEIR USE IN THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS . BIOVITRUM AB (SE) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142269-A1 New compounds GPR119, GLP1R, IAPP HRH4 839/4885CYP3A4 588/4885ALDH1A1 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.